Evidence map›Paper›PMID 42587026›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2026

Paternal epigenetic inheritance increases susceptibility to methamphetamine taking.

Sarah E Swinford-Jackson, BaDoi N Phan, Azadeh Jadali, Mateo Sarmiento Bustamante, Sharvari Mankame, Samantha J Worobey, Tyler J Sacko, Dominick Gangemi, Yixiao Zhu, Andreas R Pfenning and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Sarah E Swinford-JacksonRutgers Addiction Research Center at the Brain Health Institute and Department of Psychiatry, Rutgers Health, Piscataway, NJ, 08854, USA.
BaDoi N PhanComputational Biology Department, School of Computer Science, Carnegie Mellon University, Pittsburgh, PA, 15213, USA.ORCID http://orcid.org/0000-0001-6331-5980
Azadeh JadaliDepartment of Cell Biology and Neuroscience, W. M. Keck Center for Collaborative Neuroscience, Rutgers University, Piscataway, NJ, 08854, USA.
Mateo Sarmiento BustamanteCenter for Neurobiology and Behavior, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Sharvari MankameRutgers Addiction Research Center at the Brain Health Institute and Department of Psychiatry, Rutgers Health, Piscataway, NJ, 08854, USA.
Samantha J WorobeyRutgers Addiction Research Center at the Brain Health Institute and Department of Psychiatry, Rutgers Health, Piscataway, NJ, 08854, USA.
Tyler J SackoRutgers Addiction Research Center at the Brain Health Institute and Department of Psychiatry, Rutgers Health, Piscataway, NJ, 08854, USA.ORCID http://orcid.org/0009-0000-8940-2476
Dominick GangemiRutgers Addiction Research Center at the Brain Health Institute and Department of Psychiatry, Rutgers Health, Piscataway, NJ, 08854, USA.
Yixiao ZhuComputational Biology Department, School of Computer Science, Carnegie Mellon University, Pittsburgh, PA, 15213, USA.
Andreas R PfenningComputational Biology Department, School of Computer Science, Carnegie Mellon University, Pittsburgh, PA, 15213, USA.
Kelvin Y KwanDepartment of Cell Biology and Neuroscience, W. M. Keck Center for Collaborative Neuroscience, Rutgers University, Piscataway, NJ, 08854, USA.
Ronald P HartDepartment of Cell Biology and Neuroscience, W. M. Keck Center for Collaborative Neuroscience, Rutgers University, Piscataway, NJ, 08854, USA.
R Christopher PierceRutgers Addiction Research Center at the Brain Health Institute and Department of Psychiatry, Rutgers Health, Piscataway, NJ, 08854, USA. chris.pierce@rutgers.edu.

Funding

Molecular mechanisms of incubation of methamphetamine cravingK01DA058168 · NIDA · TEXAS A&M UNIVERSITY · PI Sarah E. Swinford-Jackson · 2024 to 2026
$597k
Integrating primate-rodent cell types and epigenomics to identify conservation in substance addictionF30DA053020 · NIDA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI PHAN, BADOI NGUYEN · 2021 to 2024
$204k
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) MH131296U.S. Department of Health & Human Services | NIH | National Institute on Deafness and Other Communication Disorders (NIDCD) DC22483U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA) DA046585U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA) DA33641U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA) F30 DA053020U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA) K01DA058168
6 · The paper itself

Abstract

We previously demonstrated that male progeny of cocaine-experienced sires resisted cocaine, expressed as delayed acquisition of cocaine self-administration. Here, we sought to determine whether this phenotype extended to another psychostimulant, methamphetamine (meth). Sires self-administered meth or cocaine or received yoked-saline infusions for 60 days, after which they were mated to naïve females. Some behaviors previously altered in cocaine-sired male rats, including object memory and anxiety-like behavior, were not influenced by paternal meth taking. In contrast to cocaine resistance in cocaine-sired male rats, meth-sired male offspring demonstrated increased susceptibility to meth taking, with no effect in females. Single nuclei RNA- and ATAC-sequencing of the nucleus accumbens was used to identify molecular drivers of phenotypes in cocaine- and meth-sired offspring. Sequencing results revealed unique profiles of gene expression and open chromatin in offspring nucleus accumbens. Differential gene expression in cocaine-resistant, cocaine-sired offspring and meth-susceptible, meth-sired offspring illuminates potential novel treatment targets for psychostimulant use disorders.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.